Literature DB >> 17049214

Development and characterization of new insulin containing polysaccharide nanoparticles.

Bruno Sarmento1, António Ribeiro, Francisco Veiga, Domingos Ferreira.   

Abstract

A nanoparticle insulin delivery system was prepared by complexation of dextran sulfate and chitosan in aqueous solution. Parameters of the formulation such as the final mass of polysaccharides, the mass ratio of the two polysaccharides, pH of polysaccharides solution, and insulin theorical loading were identified as the modulating factors of nanoparticle physical properties. Particles with a mean diameter of 500 nm and a zeta potential of approximately -15 mV were produced under optimal conditions of DS:chitosan mass ratio of 1.5:1 at pH 4.8. Nanoparticles showed spherical shape, uniform size and good shelf-life stability. Polysaccharides complexation was confirmed by differential scanning calorimetry and Fourier transformed infra-red spectroscopy. An association efficiency of 85% was obtained. Insulin release at pH below 5.2 was almost prevented up to 24h and at pH 6.8 the release was characterized by a controlled profile. This suggests that release of insulin is ruled by a dissociation mechanism and DS/chitosan nanoparticles are pH-sensitive delivery systems. Furthermore, the released insulin entirely maintained its immunogenic bioactivity evaluated by ELISA, confirming that this new formulation shows promising properties towards the development of an oral delivery system for insulin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17049214     DOI: 10.1016/j.colsurfb.2006.09.012

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  27 in total

Review 1.  Designing polymers with sugar-based advantages for bioactive delivery applications.

Authors:  Yingyue Zhang; Jennifer W Chan; Alysha Moretti; Kathryn E Uhrich
Journal:  J Control Release       Date:  2015-09-28       Impact factor: 9.776

Review 2.  Non-invasive administration of biodegradable nano-carrier vaccines.

Authors:  Mohd Abul Kalam; Abdul Arif Khan; Aws Alshamsan
Journal:  Am J Transl Res       Date:  2017-01-15       Impact factor: 4.060

3.  A composite polyelectrolytic matrix for controlled oral drug delivery.

Authors:  Priya Bawa; Viness Pillay; Yahya Essop Choonara; Lisa Claire du Toit; Valence Methaius Kessy Ndesendo; Pradeep Kumar
Journal:  AAPS PharmSciTech       Date:  2011-01-12       Impact factor: 3.246

4.  Polyethylene glycol on stability of chitosan microparticulate carrier for protein.

Authors:  Manee Luangtana-Anan; Sontaya Limmatvapirat; Jurairat Nunthanid; Rapeepun Chalongsuk; Keiji Yamamoto
Journal:  AAPS PharmSciTech       Date:  2010-09-04       Impact factor: 3.246

5.  Hybrid drug delivery system for oropharyngeal, cervical and colorectal cancer - in vitro and in vivo evaluation.

Authors:  Mohamed S Pendekal; Pramod K Tegginamat
Journal:  Saudi Pharm J       Date:  2012-08-11       Impact factor: 4.330

6.  Controlled release of repifermin from polyelectrolyte complexes stimulates endothelial cell proliferation.

Authors:  Min Huang; Cory Berkland
Journal:  J Pharm Sci       Date:  2009-01       Impact factor: 3.534

7.  Design and evaluation of a novel nanoparticulate-based formulation encapsulating a HIP complex of lysozyme.

Authors:  Ripal Gaudana; Mitan Gokulgandhi; Varun Khurana; Deep Kwatra; Ashim K Mitra
Journal:  Pharm Dev Technol       Date:  2012-11-09       Impact factor: 3.133

8.  Labeling Monomeric Insulin with Renal-Clearable Luminescent Gold Nanoparticles.

Authors:  Rodrigo D Vinluan; Mengxiao Yu; Melissa Gannaway; Justin Sullins; Jing Xu; Jie Zheng
Journal:  Bioconjug Chem       Date:  2015-10-14       Impact factor: 4.774

9.  Synergetic effects of doxycycline-loaded chitosan nanoparticles for improving drug delivery and efficacy.

Authors:  Natasha F Cover; Susana Lai-Yuen; Anna K Parsons; Arun Kumar
Journal:  Int J Nanomedicine       Date:  2012-06-25

10.  Development and characterization of chitosan-polycarbophil interpolyelectrolyte complex-based 5-fluorouracil formulations for buccal, vaginal and rectal application.

Authors:  Mohamed S Pendekal; Pramod K Tegginamat
Journal:  Daru       Date:  2012-10-25       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.